Drug profile · INN
dextroamphetamine sulfate
DEXEDRINE
dextroamphetamine sulfate (DEXEDRINE) is a norepinephrine transporter releasing agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — dextroamphetamine sulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
dextroamphetamine sulfate (DEXEDRINE) is a norepinephrine transporter releasing agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter releasing agent
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dextroamphetamine sulfate?
dextroamphetamine sulfate (DEXEDRINE) is a norepinephrine transporter releasing agent. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dextroamphetamine sulfate?
DEXEDRINE is a marketed brand name for dextroamphetamine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dextroamphetamine sulfate?
dextroamphetamine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.